Sowell Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sowell Financial Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-553	Closed	-$333K	–	778
2021 Q1	$333K	Buy	553 +470	+566%	+$278K	0.01%	795
2020 Q4	$48K	Sell	83 -95	-53%	-$54.1K	﹤0.01%	1416
2020 Q3	$92K	Sell	178 -100	-36%	-$50.6K	﹤0.01%	995
2020 Q2	$126K	Buy	278 +180	+184%	+$79.4K	0.01%	894
2020 Q1	$34K	Sell	98 -54	-36%	-$19.9K	﹤0.01%	1179
2019 Q4	$56K	Buy	152 +148	+3,700%	+$52.2K	﹤0.01%	1118
2019 Q3	$1K	Buy	+4	New	+$1.3K	﹤0.01%	2196

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's BIO Position: Q2 2021 in Review

Sowell Financial Services sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 553 shares — an estimated $333K sold.

Sowell Financial Services first reported a position in BIO in Q3 2019 and held it in 7 quarters. The position peaked at $333K in Q1 2021. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

Sowell Financial Services reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 553 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $333K.
Sowell Financial Services first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 7 quarters.
Sowell Financial Services's Bio-Rad Laboratories Class A position peaked at $333K in Q1 2021.
509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.